Table 1.
Examples of types of prescribing alerts with descriptions and hierarchy of alerts
Types of alerts |
||||
---|---|---|---|---|
Hierarchy of alerts |
Drug contraindication | Drug-drug interaction | Dose-range checking | |
Low-level (minor severity) | Description | Used when the presence of a coded contraindication (usually disease state) means that the use of the medicine could be harmful | Used for combinations of medicines which in certain circumstances could cause harm | Use of a drug probably outside clinically acceptable or usual limits for dose quantity or timing, but risk of harm not considered high |
Specific system example | Atorvastatin (a cholesterol-lowering drug) should be used caution with renal impairment due to the risk of side-effects of muscle inflammation | The use of atenolol and diuretics (both drugs used in hypertension) together may cause low blood pressure | Daily dose warning limit for beclometasone nose drops is 18 drops | |
Intermediate (moderate severity) | Description | Used when the presence of a coded contraindication (usually disease state) means that the use of the medicine may be potentially hazardous and requires avoidance or other precautions | Used for potentially hazardous interactions of drugs which require avoidance or other special cautions | Use of a drug outside clinically acceptable limits for dose quantity or timing based upon the likelihood of severe harm with that dose the usual dosing of that drug |
Specific system example | Aspirin should not be given in the presence of gastrointestinal ulceration due to the risk of bleeding | Using methotrexate and ciclosporin (both immunosuppresants) together can lead to toxicity | The infusion rate of vancomycin (antibiotic) is limited to 600 mg/h; a higher rate may cause ‘red man’ syndrome or hypotension | |
High-level messages (hard stop) | Description | Used when the presence of a coded contraindication (usually disease state) prohibits the prescription due to risk of harm | Used for combinations of drugs that should be avoided in all situations | Use of a drug significantly outside clinically acceptable limits for dose quantity or timing based upon the likelihood of serious harm with that dose |
Specific system example | Abciximab (a potent drug used to prevent thrombosis in cardiac patients) is not prescribable to patients with brain tumours due to high risk of bleeding | The antibiotic erythromycin and the antipsychotic pimozide are disallowed in combination due to risk of potentially fatal cardiac rhythm abnormality | Amphotericin (Abelcetan) – an antifungal drug – > 6 mg/kg is associated with severe toxicity at any higher weight-based doses |